Gastroesophageal reflux disease

Related records

Broader conditions (10)

• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Disease of genetic or genomic mechanism
• Esophageal disorder
• Hereditary disease
• Human disease
• Stomach disorder
• Upper digestive tract disorder

Narrower conditions (1)

• Duodenogastric reflux

Trials (1,222)

• "The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
• [Impedance Measurement for Non-Erosive Reflux Disease
• 14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations
• 2019-06 TRISCEND Study
• 48 Hours Esophagal pH-monitoring With and Without Gaviscon
• 7 Year Follow up Analysis on the Speed of Progression of Tooth Wear Using 3D Subtraction
• 9-Step Magnetic Bariatric Revisional Surgery
• A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD
• A Clinical Trial of PepZinGI® for Acute Heartburn Relief and Sleep Outcomes
• A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion
• A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes
• A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease
• A Comparison of Cosmos Rx Medication Adherence Platform vs. Pharmacy Fill Adherence Measures
• A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
• A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
• A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
• A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
• A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
• A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
• A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

Approved drugs (30)

• Bismuth subcitrate potassium
• Carbenoxolone
• Carbenoxolone sodium
• Cimetidine
• Cimetidine hydrochloride
• Cisapride
• Cisapride monohydrate
• Dexlansoprazole
• Esomeprazole magnesium
• Esomeprazole potassium
• Esomeprazole sodium
• Esomeprazole strontium
• Famotidine
• Irsogladine maleate
• Lansoprazole
• Misoprostol
• Nizatidine
• Omeprazole
• Omeprazole sodium
• Pantoprazole sodium

Drugs in development (65)

• Abeprazan Phase 3
• Acetoxolone
• AD-214 Phase 1
• Alginic acid Phase 3
• Anaprazole Phase 3
• Arbaclofen placarbil Phase 2
• Atovaquone Phase 1
• AZD1386 Phase 2
• AZD2066 Phase 1
• AZD2516 Phase 2
• Azeloprazole sodium Phase 1
• Baclofen Phase 3
• Budesonide Phase 2
• Buspirone Phase 1
• Calcium carbonate Phase 1
• Charcoal, activated Phase 2
• Colesevelam hydrochloride Phase 3
• Desipramine Phase 3
• Domperidone Phase 3
• Enprostil Phase 2

Other linked drugs (28)

• Almagate
• Aluminum hydroxide
• Amitriptyline
• Amoxicillin
• Chlorpromazine
• Citalopram
• Clarithromycin
• Deoxycholic acid
• Erythromycin
• Erythromycin gluceptate
• Erythromycin stearate
• Esmolol
• Hyaluronic acid
• Hydrotalcite
• Hydrotalcite anhydrous
• Imipramine pamoate
• Lidocaine
• Lidocaine hydrochloride
• Magnesium
• Magnesium hydroxide